Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI
Image Credits: Bloomberg / Contributor Tempus, a genomiRead More
Image Credits: Bloomberg / Contributor Tempus, a genomiRead More
Image Credits: Bloomberg / Contributor Tempus, a genomiRead More